Xgluzit

Xgluzit is a dapagliflozin tablet used to improve glycemic control in type 2 diabetes.

Type:

Antidiabetic

Classification:

SGLT2 Inhibitor

#ANTIDIABETIC #DPP4 #GLUCOSE

Product Overview

Xgluzit is a dapagliflozin tablet used to improve glycemic control in adults with type 2 diabetes.

Composition

  • Dapagliflozin

Formulation

Tablet

Key Benefits

  • Effective glycemic control
  • Low risk of hypoglycemia
  • Weight neutral

Indications

  • Type 2 diabetes mellitus
  • As monotherapy or combination therapy
  • When metformin is contraindicated

Marketed By

Vee Medi Biotech